Treatment late effects in long-term survivors of pediatric sarcoma.

Purpose: To assess health and musculoskeletal function in survivors of pediatric sarcomas.

Patients And Methods: Thirty-two individuals treated for Ewing sarcoma family of tumors (ESFT), rhabdomyosarcoma (RMS), or non-rhabdomyosarcoma soft tissue sarcomas (NR-STS) with multi-modality therapy were enrolled on this cross-sectional study. Median age at the time of therapy was 15.